OpenResearchAlpha

Obstetrics & Gynecology · 10 Nov 2026

Hospital-Level Variation in Antenatal Corticosteroid Use for Late Preterm Births

Mark A. Clapp, Dohyun Lee, Siguo Li, Kaitlyn E. James, Scott A. Lorch, Jessica L. Cohen, Jason D. Wright, Cynthia Gyamfi-Bannerman, Anjali J. Kaimal, Alexander Melamedh-index 26

0
Citations
no database records one yet
0
Citations in 2026
so far
26
Leading author's h-index
Alexander Melamed, in QAI's scholar index
19
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

OBJECTIVE: To determine whether and to what extent hospitals across the United States vary in their use of late preterm steroids. METHODS: This was a retrospective cohort study of singleton births with known gestational ages identified in the Premier Healthcare Database from 2015 to 2022. The primary variable of interest was hospital-level adoption of antenatal corticosteroid use for late preterm singleton deliveries, calculated as the proportion of late preterm singleton births (34–36 completed weeks of gestation) with any betamethasone exposure during the same late preterm period. Hospital adoption was defined as the weighted average rate of steroid administration among late preterm births across the entire postperiod. Hospitals were ranked by their late preterm steroid adoption rates and categorized by quartile based on the empirical distribution. Temporal trends were assessed using annual hospital-level adoption rates and visualized using time series plots and distributional plots. A logistic regression model was constructed to identify hospital characteristics associated with being a highest-quartile adopter. RESULTS: The analysis cohort included 726 hospitals and 5,109,270 births, of which 309,837 (6.1%) were singleton late preterm births. Hospital steroid exposure rates ranged from 0% to 92% and were categorized into quartiles based on overall exposure rate, with cutoffs at 22.4%, 33.9%, and 45.1%. Median exposure rates increased progressively across quartiles, from 15.4% (IQR 10.0–18.9%) in the lowest-adopting hospitals (quartile 1) to 54.3% (IQR 49.1–61.0%) in the highest-adopting hospitals (quartile 4), with substantial within-quartile variation. In the multivariable model, urban location was a strong predictor of high adoption after adjustment (adjusted odds ratio [aOR] 2.03; 95% CI, 1.04–4.02, P =.04). Compared with Midwestern hospitals, Southern hospitals had significantly lower odds of being high adopters (aOR 0.32; 95% CI, 0.17–0.61, P <.001). Among clinical case mix variables, a higher proportion of late preterm births at 34 weeks of gestation was strongly associated with high adoption (aOR 2.39; 95% CI, 1.73–3.36, P <.001). CONCLUSION: After the publication of the ALPS (Antenatal Late Preterm Steroids) trial, the adoption of late preterm steroid use was heterogeneous among U.S. hospitals. These findings highlight the need for a more in-depth exploration of local factors that drive the adoption of evidence-based practices outside of observable hospital characteristics.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Alexander Melamed has the highest h-index among the authors (26).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (10)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (19)

What it cites, from open citation data, with Crossref's record of each.